Get started
Author

George Sfikas

Observed names: G. Sfikas, Sfikas, George
ORCID: 0000-0001-6260-7658
Observed ORCID: 0000-0001-6260-7658
OpenAlex ID: A5010483333
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021 · Antonio J. Vallejo-Vaz, Christophe A.T. Stevens, et al. · The Lancet · 339
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
2023 · Kanika Inamdar Dharmayat, Antonio J. Vallejo-Vaz, et al. · The Lancet · 92
PDF
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
2004 · Vasilia Garypidou, Sofia Vakalopoulou, et al. · PubMed · 61
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
2021 · Christos V. Rizos, Ioannis Skoumas, et al. · International Journal of Cardiology · 29
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024 · Amany Elshorbagy, Alexander R.M. Lyons, et al. · The Lancet Diabetes & Endocrinology · 17
Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
2020 · Christos V. Rizos, Matilda Florentin, et al. · Lipids in Health and Disease · 12
PDF
Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry
2024 · Christina Antza, Christos V. Rizos, et al. · Biomedicines · 10
PDF
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry
2024 · Fotios Barkas, Christos V. Rizos, et al. · Journal of clinical lipidology · 8
Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH
2022 · Panagiotis Anagnostis, Christos V. Rizos, et al. · Endocrine · 8
The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients
2024 · Chrysoula Boutari, Christos V. Rizos, et al. · Clinical Nutrition · 7
Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
2022 · Chrysoula Boutari, Christos V. Rizos, et al. · Pharmaceuticals · 7
PDF
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins
2017 · Vasilios G. Athyros, Konstantinos Tziomalos, et al. · Current Pharmaceutical Design · 7
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry
2024 · Loukianos S. Rallidis, Christos V. Rizos, et al. · Journal of Cardiovascular Medicine · 6
Prevalence of Non-coronary Heart Disease in Patients with Familial Hypercholesterolemia: An Analysis from the HELLAS-FH
2021 · Panagiotis Anagnostis, Christos V. Rizos, et al. · Current Pharmaceutical Design · 6
Beyond lipid levels: unraveling the hypertensive factor in familial hypercholesterolemia. The HELLAS-FH registry
2025 · Christina Antza, Christos V. Rizos, et al. · Journal of Human Hypertension · 3
Exploring the correlation between triglyceride levels and atherosclerotic cardiovascular disease prevalence in adults with familial hypercholesterolemia: Insights from a cross-sectional analysis in the HELLAS-FH registry
2025 · Panagiotis Anagnostis, Christos V. Rizos, et al. · Journal of clinical lipidology · 2
Prevalence of non-coronary heart disease in patients with familial hypercholesterolemia: An analysis from the HELLAS-FH
2021 · P. Anagnostis, C. Rizos, et al. · Atherosclerosis · 2
EDITORIAL: Is the Beneficial Effect of Mediterranean Diet on Cardiovascular Risk Partly Mediated through Better Blood Pressure Control?
2013 · Panagiotis Anagnostis, George Sfikas, et al. · The Open Hypertension Journal · 2
PDF
Inflammation and LDL Reduction
2022 · Vasilios Gabriel Athyros, George Sfikas, et al. · Current Vascular Pharmacology · 1
2013 American College of Cardiology/American Heart Association Lipid Guidelines after the 2016 American College of Cardiology Expert Panel Consensus Statement: To err is human; to admit it, divine
2016 · Vasilios G. Athyros, George Sfikas, et al. · 1
Association of Estimated Glucose Disposal Rate (egdr) With Established Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia: an Analysis From the Hellas-fh Registry
2026 · Christos Rizos, George Liamis, et al. · Atherosclerosis
Correlation of Dutch Lipid Clinical Network (dlcn) Categories With Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia: an Analysis From the Hellas-fh Registry
2026 · Christos Rizos, George Liamis, et al. · Atherosclerosis
Treatment Eligibility With Icosapent Ethyl in Patients With Familial Hypercholesterolemia: Data From the Hellas-fh Registry
2026 · Christos Rizos, George Liamis, et al. · Atherosclerosis
Estimated Small Dense LDL Cholesterol and Coronary Artery Disease in Familial Hypercholesterolemia
2026 · Dimitrios Delialis, Christos V. Rizos, et al. · Journal of Atherosclerosis and Thrombosis
PDF
HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol
2025 · Christos V. Rizos, Genovefa Kolovou, et al. · Endocrine
Works count: 55
Citation count: 620
H-index: 8
I10-index: 7
Year
Topic
Type